Jpmorgan Chase & CO Assertio Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 10,478 shares of ASRT stock, worth $9,849. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,478
Previous 14,614
28.3%
Holding current value
$9,849
Previous $18,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ASRT
# of Institutions
97Shares Held
31MCall Options Held
957KPut Options Held
38.5K-
Nantahala Capital Management, LLC New Canaan, CT8.95MShares$8.41 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$4.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.23MShares$3.04 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.3 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.26MShares$1.18 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $45.3M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...